Cargando…
Wisconsin’s Screening Algorithm for the Identification of Newborns with Congenital Adrenal Hyperplasia
Newborn screening for congenital adrenal hyperplasia (CAH) has one of the highest false positive rates of any of the diseases on the Wisconsin panel. This is largely due to the first-tier immune assay cross-reactivity and physiological changes in the concentration of 17-hydroxyprogesterone during th...
Autores principales: | Bialk, Eric R., Lasarev, Michael R., Held, Patrice K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510207/ https://www.ncbi.nlm.nih.gov/pubmed/33072992 http://dx.doi.org/10.3390/ijns5030033 |
Ejemplares similares
-
Newborn Screening for Congenital Adrenal Hyperplasia: Review of Factors Affecting Screening Accuracy
por: Held, Patrice K., et al.
Publicado: (2020) -
Newborn screening for congenital adrenal hyperplasia in New York State
por: Pearce, Melissa, et al.
Publicado: (2016) -
Landscape of Congenital Adrenal Hyperplasia Newborn Screening in the United States
por: Edelman, Sari, et al.
Publicado: (2020) -
Impact of Newborn Screening on Clinical Presentation of Congenital Adrenal Hyperplasia
por: Navardauskaitė, Rūta, et al.
Publicado: (2021) -
Moderate congenital adrenal hyperplasia in two girls diagnosed by newborn screening
por: Banaszak-Ziemska, Magdalena, et al.
Publicado: (2021)